Apyx Medical appoints Matthew Hill as CFO effective Dec 4, 2023

Apyx Medical Corp

Matthew Hill appointed CFO, effective Dec 4, 2023, succeeding Tara Semb who departed Nov 9.
Hill brings 30+ years experience, previously CFO of PDS Biotech, Strata Skin Sciences, and other healthcare firms.
Employment terms: $425K base salary, $50K sign-on bonus, target bonus ≥50% of base, stock option for 150K shares.
Hill will also serve as Principal Financial Officer and Principal Accounting Officer.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Matthew Hill

Chief Financial Officer

APYX · Apyx Medical Corp

Effective: 2023-12-04
Filed: November 28, 2023, 6:59 PM ET

On November 28, 2023, Apyx Medical Corporation (the “Company”) announced that it had appointed Matthew Hill as its Chief Financial Officer, effective December 4, 2023 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Hill was appointed as Chief Financial Officer at Apyx Medical Corp.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On November 28, 2023, Apyx Medical Corporation (the “Company”) announced that it had appointed Matthew Hill as its Chief Financial Officer, effective December 4, 2023 (the “Effective Date”).

View on SEC.gov

Apyx Medical Corp filing history →

Source: SEC EDGAR

accession 0000719135-23-000066

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.